ResearcherTaizhou Central HospitalActive in the last 2 years

Fei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4695-944X; OpenAlex author ID A5100325828. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Downregulation of miR-503-5p Promotes the Development of Pancreatic Cancer by Targeting Cyclin E2. Co-author DOI 10.1615/critrevimmunol.2024051136 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jie Zhu · 1 shared paper, 2024 · strength 0.26
- Paper Downregulation of miR-503-5p Promotes the Development of Pancreatic Cancer by Targeting Cyclin E2. DOI 10.1615/critrevimmunol.2024051136 ↗
Hao Jiang · 1 shared paper, 2024 · strength 0.26
- Paper Downregulation of miR-503-5p Promotes the Development of Pancreatic Cancer by Targeting Cyclin E2. DOI 10.1615/critrevimmunol.2024051136 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.